A Study to Evaluate Luspatercept Utilization in Patients With Lower Risk Myelodysplastic Syndromes or Beta-thalassemia

Clinical trial NCT07681440 · TERMINATED

Trial details

NCT number: NCT07681440
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Study type: OBSERVATIONAL

Myelodysplastic Syndromes Beta-thalassemia

Start date: 2023-11-16
Primary completion: 2025-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.